Peripheral neuropathy Board decisions

The Board granted service connection for major depressive disorder but denied it for obstructive sleep apnea and right hand neuropathy. The claims for left hip sprain and lumbosacral strain were remanded.

The Board granted initial 40 percent ratings for peripheral neuropathy of the left and right lower extremities, as well as separate service connection for moderate incomplete paralysis of the superficial peroneal nerve in both legs, and a total disability rating based on individual unemployability (TDIU) prior to January 28, 2020.

The Board remands the claims for further development and readjudication.

The Board granted service connection for multiple disabilities, including various musculoskeletal conditions and mental health disorders.

The Board granted service connection for idiopathic peripheral polyneuropathy in both the right and left lower extremities, finding a causal relationship to Agent Orange exposure.

The Board granted service connection for idiopathic peripheral polyneuropathy in both the right and left lower extremities, finding a causal relationship to Agent Orange exposure.

The Board denied the Veteran's claim for financial assistance in the purchase of an automobile or other conveyance, or adaptive equipment due to a lack of evidence supporting permanent loss of use of his hands and feet.

The Board granted service connection for idiopathic peripheral polyneuropathy in both the right and left lower extremities, finding a causal relationship to Agent Orange exposure.

The Board granted service connection for diabetes mellitus type II with erectile dysfunction, right and left lower extremity diabetic neuropathies (sciatic and femoral nerves), and hypertension, all as due to herbicide exposure on a facts-found basis.

The Board granted service connection for idiopathic peripheral polyneuropathy in both the right and left lower extremities, finding a causal relationship to Agent Orange exposure.

The Board granted service connection for left and right lower extremity peripheral neuropathy, other than under the PACT Act, as well as coronary artery disease, on a presumptive basis due to herbicide exposure.

The Board granted service connection for idiopathic peripheral polyneuropathy in both the right and left lower extremities, finding a causal relationship to Agent Orange exposure.

The Board granted service connection for idiopathic peripheral polyneuropathy in both the right and left lower extremities, finding a causal relationship to Agent Orange exposure.

The Board granted service connection for idiopathic peripheral polyneuropathy in both the right and left lower extremities, finding a causal relationship to Agent Orange exposure.

The Board granted service connection for idiopathic peripheral polyneuropathy in both the right and left lower extremities, finding a causal relationship to Agent Orange exposure.

The appeal for service connection for multiple conditions was dismissed due to the untimely filing of the Board Appeal request.

The Board denied the Veteran's claims for increased ratings for diabetic peripheral neuropathy in both upper and lower extremities, finding that the symptoms did not warrant a higher rating.

The Board granted service connection for various conditions, including neck disability manifested by pain and diabetes mellitus type II, secondary to the Veteran's service-connected bilateral knee degenerative arthritis. The other conditions were also granted as they are caused by the now-service-connected diabetes mellitus type II.

The Board granted a rating of 40 percent disabling for neuropathy, peripheral conditions affecting the right and left lower extremities (sciatic nerve), with an effective date of February 20, 2023.

The Board granted an effective date of March 2, 2023 for heart disease and September 28, 2023 for chronic renal failure, while denying earlier effective dates for PTSD, migraines, diabetes mellitus type II, hypertension, and bilateral hearing loss. The Board also granted a 70 percent evaluation for PTSD.